Bioactivity:

1. Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions. 2. Byakangelicol can inhibit IL-1beta-induced PGE2 release in A549 cells; this inhibition may be mediated by suppression of COX-2 expression and the activity of COX-2 en

CAS nr:

26091-79-2

Purity:

98%

Molecular Weight:

316,3

SMILES:

COc1c2ccoc2c(OC[C@H]2OC2(C)C)c2oc(=O)ccc12

Formula:

C17H16O6

Pathway:

Neuroscience,Immunology/Inflammation

Target:

COX,COX